Published since 1965, Laser Focus World provides comprehensive global coverage of optics, photonics, and optoelectronic technologies, applications, and markets. With 80,000+ qualified print subscribers and over a half-million annual visitors to our online content, we are the go-to source to access decision makers and stay in-the-know.

In addition to providing in-depth articles written by Laser Focus World editors, Laser Focus World accepts articles, news stories, and new product information for publication from qualified outside contributors. 

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Subscribe

A Laser Focus World newsletter subscription is free to qualified professionals. Subscribe here.

Get Published!

Laser Focus World welcomes original, bylined contributed articles for publishing, provided the material is non-commercial and runs first on our site. For consideration, contact Sally Cole Johnson ([email protected]). For more information, see our Editorial Guidelines

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics. Watch here.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community. Listen here.

Contact Us

Newsletter Archive

Magazine Archive

Meet the Laser Focus World Team

Editorial

Contact Sales

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology

New to The Street to Broadcast Live on Bloomberg Tonight at 6:30 PM EST as Sponsored Programming, Spotlighting BioVie (BIVI), RoadZen (RDZN), HPB, and Sustainable Innovation With Shark Tank’s Kevin Harrington and Sustainable Green Team (SGTM)

NEW YORK, NY / ACCESS Newswire / February 22, 2025 / New to The Street is set to deliver an engaging broadcast on Bloomberg Television this evening at 6:30 PM EST as sponsored programming. The show will spotlight breakthrough companies and innovative market strategies that are shaping the future of healthcare, technology, and sustainable development.

A key highlight of the broadcast will be an exclusive segment with BioVie Inc. (NASDAQ: BIVI) CEO Cuong Do speaking with Jane King about the company's investigational drug bezisterim, Do revealed that the drug has shown promising clinical benefits: Parkinson's patients are experiencing improved muscle control, and Alzheimer's patients have demonstrated a 68% slowing of cognitive decline compared to placebo after just six months of treatment. Potentially the first new therapy for Parkinsons in over 50 years. The new clinical study is enrolling now go to Sunrisepd.com for more info.

In addition, the program will feature:

  • Roadzen Inc. (Nasdaq:RDZN): A global technology company transforming auto insurance with advanced artificial intelligence (AI), driving innovation in telematics, generative AI, and computer vision. Rohan Malhotra , the CEO of RoadZen, explained that as cars evolve into highly connected devices-essentially "iPhones on wheels"-there's going to be a wave of innovation not just in the vehicles themselves but in all the related services. Here's what he outlined:

  • Expanding Ecosystem: As vehicles become more digitally advanced, areas such as identity verification, cybersecurity, in-car entertainment, and insurance will see rapid innovation.

  • Insurance Challenges: For auto insurance, the key decisions involve:

    • Pricing: Determining the right premium.

    • Selling: Effectively marketing and distributing policies.

    • Claims Processing: Handling claims quickly and fairly.

    • Safety: Enhancing vehicle safety, which in turn can lower risk and improve profitability.

  • RoadZen's AI Advantage:
    RoadZen uses proprietary AI algorithms to simplify these four critical areas. By doing so, they aim to:

    • Lower underwriting costs.

    • Reduce premiums.

    • Increase transparency in the insurance process.

In essence, RoadZen's mission is to harness AI to transform auto insurance into a more efficient, customer-friendly, and cost-effective service as our cars become smarter and more connected.

  • HPB: A pioneering company specializing in next-generation, solid-state batteries that are non-flammable, extremely durable, and environmentally friendly.

  • Sustainable Innovation Segment: Featuring Shark Tank's Kevin Harrington alongside the Sustainable Green Team (SGTM), leaders in providing sustainable, eco-friendly solutions focused on improving soil health and ecological stability.

Tune in tonight on Bloomberg Television for in-depth interviews, exclusive insights, and a look at the innovations driving advancements across multiple industries.

About BioVie Inc.
BioVie Inc. (NASDAQ: BIVI) is a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders (long COVID, AD and PD) and advanced liver disease. In neurodegenerative disease, the Company's drug candidate bezisterim inhibits inflammatory activation of extracellular signal-regulated kinase and the transcription factor nuclear factor-κB, and the associated neuroinflammation and insulin resistance but not ERK and NFκB homeostatic functions (e.g., insulin signaling and neuron growth and survival). Both neuroinflammation and insulin resistance are drivers of AD and PD. Persistent systematic inflammation and neuroinflammation are key features in patients with neurological symptoms of long COVID. In liver disease, the Company's Orphan drug candidate BIV201 (continuous infusion terlipressin), with FDA Fast Track status, is being evaluated and discussed with guidance received from the FDA regarding the design of Phase 3 clinical testing of BIV201 for the reduction of further decompensation in participants with liver cirrhosis and ascites. The active agent is approved in the U.S. and in about 40 countries for related complications of advanced liver cirrhosis. For more information, visit www.bioviepharma.com.

About Roadzen Inc.
Roadzen Inc. (Nasdaq:RDZN) is a global technology company transforming auto insurance using advanced artificial intelligence (AI). Thousands of clients-from the world's leading insurers and carmakers to fleets and dealerships-utilize Roadzen's technology to build new products, process claims, and enhance road safety. To learn more, visit www.roadzen.ai.

About Sustainable Green Team (SGTM)
Sustainable Green Team ($SGTM) is a leading provider of environmentally sustainable solutions focused on improving soil health and ecological stability. By addressing critical environmental challenges through innovative products and services, SGTM supports sustainable agricultural and industrial practices worldwide. For more information, visit www.sustainablegreenteam.com.

About HPB
High Performance Battery Technology GmbH is a young company specializing in the research and development of next-generation batteries with outstanding properties. The HPB Solid-State Battery is characterized by its non-flammability, extreme durability, and significantly improved environmental profile - and is already ready for series production due to an innovative manufacturing process. Based in Bonn, Germany, HPB is a wholly owned subsidiary of High Performance Battery Holding AG, based in Teufen, Switzerland, which finances its research. For additional details, visit highperformancebattery.ch.

About New to The Street
New to The Street is a premier broadcast program with over 16 years in business, dedicated to delivering insightful commentary and in-depth analysis on emerging trends in healthcare, technology, and sustainability. Now on show number 630, the program boasts over 2.2 million YouTube subscribers and more than 600,000 followers and subscribers across X, LinkedIn (company-wide), Instagram, and Facebook, reaching over 800 million homes nationwide through real TV broadcasting every month. With exclusive interviews and breakthrough stories, New to The Street is your go-to source for market insights and innovative developments. (51) New to The Street TV - YouTube

The show is sponsored by ACURX Pharmaceuticals $ACXP https://youtu.be/3U--JarssP0?si=EEnlcPTKG2YbjbmO

Contact Information

Monica Brennan
Head of Operations
monica@newtothestreet.com

SOURCE: New to The Street

Related Images



View the original press release on ACCESS Newswire

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.